Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep:19 Suppl 1:22-29.
doi: 10.1111/dom.12995.

β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy

Susumu Seino  1 , Kenji Sugawara  1   2 , Norihide Yokoi  1 , Harumi Takahashi  1
Affiliations
Review

β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy

Susumu Seino et al. Diabetes Obes Metab. 2017 Sep.

Abstract

Insulin secretagogues including sulfonylureas, glinides and incretin-related drugs such as dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor agonists are widely used for treatment of type 2 diabetes. In addition, glucokinase activators and G-protein-coupled receptor 40 (GPR40) agonists also have been developed, although the drugs are not clinically usable. These different drugs exert their effects on insulin secretion by different mechanisms. Recent advances in β-cell signalling studies have not only deepened our understanding of insulin secretion but also revealed novel mechanisms of insulin secretagogues. Clarification of the signalling mechanisms of the insulin secretagogues will contribute to improved drug therapy for diabetes.

Keywords: Epac2A; KATP channel; glutamate; in silico similarity search; incretin; sulfonylurea; β-cell.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms

LinkOut - more resources